Biologic scaffolds are derived from mammalian tissues, which must be decellularized to
remove cellular antigens that would otherwise incite an adverse immune response …

Decellularization of tissues and organs is a successful platform technology for creating
scaffolding materials for tissue engineering and regenerative medicine. It has been …

A key challenge to the clinical implementation of decellularized scaffold-based tissue
engineering lies in understanding the process of removing cells and immunogenic material …

Biologic scaffolds composed of extracellular matrix (ECM) are widely used in both preclinical
animal studies and in many clinical applications to repair and reconstruct tissues. Recently …

Extracellular matrix (ECM) is a natural biomaterial scaffold that provides biochemical and
structural support to its surrounding cells, forming tissue and respective organs. These ECM …

Biomaterials are a cornerstone technology of the biomedical device, tissue engineering, and
regenerative medicine industries. While traditional biomaterials are fully defined synthetics …

The natural extracellular matrix (ECM), thanks to its specific properties (eg, collagenous
lattice, a reservoir of growth factors, ECM‐cell anchoring areas, an optimal pH and CO2) …

The extracellular matrix (ECM) is a complex network with multiple functions, including
specific functions during tissue regeneration. Precisely, the properties of the ECM have been …

Decellularized tissues and organs have been successfully used in a variety of tissue
engineering/regenerative medicine applications, and the decellularization methods used …

The use of decellularised matrices as scaffolds offers the advantage of great similarity with
the tissue to be replaced. Moreover, decellularised tissues and organs can be repopulated …